Dupilumab efficacy in asthma patients with comorbid chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST

I. Pavord (Oxford, United Kingdom), L. Ford (Bellevue, United States of America), L. Sher (Rolling Hills Estates, United States of America), K. Rabe (Kiel, Germany), H. Park (Seoul, Republic of Korea), B. Cosio (Palma de Mallorca, Spain), M. Foster (Bridgewater, United States of America), H. Staudinger (Bridgewater, United States of America), J. Maroni (Tarrytown, United States of America), P. Rowe (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), G. Pirozzi (Bridgewater, United States of America), M. Ruddy (Tarrytown, United States of America), B. Akinlade (Tarrytown, United States of America), N. H. Graham (Tarrytown, United States of America), A. Teper (Bridgewater, United States of America)

Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Session: Novel immunology-based therapies in asthma and COPD
Session type: Oral Presentation
Number: 1651
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Pavord (Oxford, United Kingdom), L. Ford (Bellevue, United States of America), L. Sher (Rolling Hills Estates, United States of America), K. Rabe (Kiel, Germany), H. Park (Seoul, Republic of Korea), B. Cosio (Palma de Mallorca, Spain), M. Foster (Bridgewater, United States of America), H. Staudinger (Bridgewater, United States of America), J. Maroni (Tarrytown, United States of America), P. Rowe (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), G. Pirozzi (Bridgewater, United States of America), M. Ruddy (Tarrytown, United States of America), B. Akinlade (Tarrytown, United States of America), N. H. Graham (Tarrytown, United States of America), A. Teper (Bridgewater, United States of America). Dupilumab efficacy in asthma patients with comorbid chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST. 1651

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: